Monday, April 06, 2020 11:46:20 AM
Most recent dry eye study showed significant decrease in cytokine production when used in dry eye formulation. Protokinetix should approach the FDA regarding compassionate care exception for patients with severe disease caused by COVID-19. The damage caused to the lungs comes from a cytokine storm generated by the body in an attempt to kill the virus. Everyone contact the company and tell them to explore this idea.
Recent PKTX News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 04:34:55 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 08:15:23 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/23/2025 06:11:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 04:57:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/19/2025 10:19:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 01:36:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 08:58:10 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/15/2025 09:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/05/2025 08:15:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 05:30:59 PM
